For the individual market, 2014 was the first year Affordable Care Act medical claims experience data were available to set 2016 rates. Accessing Centers for Medicare and Medicaid Services rate data for 175 state insurers, this study compares projected medical claims with actual medical claims of 2014, as well as the cost and utilization of benefit categories for inpatient, outpatient, professional, and prescription drug spending. Actual costs per member per month (pmpm) were greater than projected in 2014 for inpatient, outpatient, and prescription spending but not for professional care. Overall, actual median medical cost was $443 pmpm, which was significantly higher by $41 than projected cost. Greater utilization of health care was primarily responsible for higher realized medical claims. In terms of the specific benefit categories-inpatient, outpatient, and prescription-actual costs pmpm were significantly higher than projected values. In terms of the drivers of inpatient costs, on an admission basis, higher costs and greater utilization of admissions resulted in higher inpatient costs. For outpatient costs pmpm, higher utilization rather than unit cost per visit drove increased costs. Higher than expected prescription drug costs were driven by both greater utilization and cost per prescription.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798701PMC
http://dx.doi.org/10.1177/0046958016673252DOI Listing

Publication Analysis

Top Keywords

medical claims
20
pmpm higher
12
greater utilization
12
projected medical
8
inpatient outpatient
8
prescription drug
8
costs
8
costs pmpm
8
inpatient costs
8
higher
7

Similar Publications

Is Hume's Law a valid argument against empirical bioethics?

Bioethics

January 2025

School of Public and Population Health, Institute for Bioethics and Health Humanities, The University of Texas Medical Branch, Galveston, Texas, USA.

If "no ought from is," how can bioethics be empirical? Despite the widespread recognition that we can integrate empirical and normative, Hume's Law is still often claimed to pose logical limitations to empirical bioethics. Is Hume's Law a valid argument against empirical bioethics? I argue that we have reasons to answer no. First, I outline and reject two unverified assumptions: that Hume' s Law, the fact-value distinction, and the naturalistic fallacy are roughly the same thing, and that Hume's Law is an undisputed meta-ethical principle which dictates how to formulate normative statements.

View Article and Find Full Text PDF

Background: Several studies reported an association between the number of teeth and the incidence of hip fractures in observational studies, mainly in middle-aged adults. This retrospective cohort study aimed to clarify the association between the number of teeth and the incidence of hip fractures.

Methods: In this retrospective cohort study, a total of 256,772 participants aged 75 years or older who underwent public dental checkups in Japan were evaluated.

View Article and Find Full Text PDF

Using a large health insurance database in Japan, we examined the real-world usage of budesonide enteric-coated capsules (BUD) in treating Crohn's disease. We analyzed data from the Japan Medical Data Center claims database for Crohn's disease patients prescribed BUD from April 2016 to March 2021, focusing on prescription status, adverse events (AEs), monitoring tests, and concomitant medications over 2 years following BUD initiation. Patients were categorized into two groups based on BUD usage duration: ≤1 year and >1 year.

View Article and Find Full Text PDF

Personalized Nutrition (PN) aims to provide tailored dietary recommendations to improve a person's health outcomes by integrating a multitude of individual-level information and support desired behavior changes. The field is rapidly evolving with technological advances. As new biomarkers are discovered, wearables and other devices can now provide up-to-the-minute insights, and artificial intelligence (AI) and machine learning (ML) models support recommendations and lifestyle behavior change.

View Article and Find Full Text PDF

Identification of an ANCA-associated vasculitis cohort using deep learning and electronic health records.

Int J Med Inform

January 2025

Rheumatology and Allergy Clinical Epidemiology Research Center and Division of Rheumatology, Allergy, and Immunology, and Mongan Institute, Department of Medicine, Massachusetts General Hospital Boston MA USA. Electronic address:

Background: ANCA-associated vasculitis (AAV) is a rare but serious disease. Traditional case-identification methods using claims data can be time-intensive and may miss important subgroups. We hypothesized that a deep learning model analyzing electronic health records (EHR) can more accurately identify AAV cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!